|
Dr. Yla-Herttuala is Professor of Molecular Medicine at A.I. Virtanen Institute for Molecular Sciences and Department of Medicine, University of Kuopio, Kuopio, Finland. Dr. Yla-Herttuala is an internationally recognized leader in cardiovascular gene therapy. His team was among the first to use adenovirus-mediated gene transfer in human arteries and since then, he has conducted several clinical trials in cardiovascular gene therapy. His group is also widely recognized for basic and applied biology research related to vascular endothelial growth factors, especially with newer members of the growth factor family. Dr. Yla-Herttuala serves on the editorial boards of several major US and European cardiovascular and gene therapy journals. He has published over 250 scientific papers and articles related to cardiovascular diseases, VEGFs, atherosclerosis, restenosis and gene therapy. | 